Regeneron Pharmaceuticals (REGN) YTD return

Updated November 02, 2026 · Data: Yahoo Finance

+25.02%
YTD return in 2026 (from Dec 31, 2025 close)
Dec 31, 2025 close$768.89
Current price$961.26
$1,000 on Dec 31 →$1,250.20
YTD rank#147 of 500
SectorHealth Care
Official websiteregeneron.com

Price chart

REGN vs its sector

Health Care sector average+29.73%
REGN YTD+25.02%
Difference-4.71 pts
Stocks in sector60

Underperforming its sector. REGN is 4.71 points behind the Health Care sector average, which covers 60 ranked S&P 500 stocks.

Regeneron Pharmaceuticals (REGN) is up +25.02% year-to-date in 2026, ranking #147 of 500 ranked S&P 500 stocks. It closed 2025 at $768.89 and trades at $961.26 as of November 02, 2026. $1,000 invested on December 31, 2025 would be worth $1,250.20 today. That puts it 4.71 points behind the Health Care sector average of +29.73%.

Recent performance

Regeneron Pharmaceuticals (REGN) has gained 30.75% over the past month, outpacing the S&P 500 by 33.10%, and gained 26.52% over the past three months (ahead of the index by 29.04%). It is trading at its 52-week high. Momentum is positive: the stock rose in at least 4 of the last 5 sessions.

Latest REGN news

Headlines via Yahoo Finance, updated daily.

Where to invest in REGN

Popular stock brokerages:

We may earn a commission if you sign up through these links, at no extra cost to you.

REGN YTD return FAQ

What is Regeneron Pharmaceuticals (REGN)'s YTD return in 2026?

Regeneron Pharmaceuticals (REGN) is up +25.02% year-to-date in 2026, as of November 02, 2026.

What was Regeneron Pharmaceuticals (REGN)'s price at the start of 2026?

Regeneron Pharmaceuticals (REGN) closed at $768.89 on December 31, 2025 and trades at $961.26 as of November 02, 2026.

Where does Regeneron Pharmaceuticals (REGN) rank by YTD return in 2026?

Regeneron Pharmaceuticals (REGN) ranks #147 of 500 S&P 500 stocks by YTD return in 2026, as of November 02, 2026.

← Full S&P 500 YTD leaderboard

For informational purposes only, not financial advice.

© 2026 MZX MEDIA LLC. All rights reserved.